| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:04:45 UTC |
|---|
| Update date | 2024-11-29 22:26:17 UTC |
|---|
| Primary ID | FDB000885 |
|---|
| Secondary Accession Numbers | |
|---|
| Chemical Information |
|---|
| FooDB Name | Hydroquinone |
|---|
| Description | Hydroquinone, also benzene-1,4-diol, is an aromatic organic compound which is a type of phenol, having the chemical formula C6H4(OH)2. Its chemical structure has two hydroxyl groups bonded to a benzene ring in a para position. Hydroquinone is commonly used as a biomarker for benzene exposure. The presence of hydroquinone in normal individuals stems mainly from direct dietary ingestion, catabolism of tyrosine and other substrates by gut bacteria, ingestion of arbutin containing foods, cigarette smoking, and the use of some over-the-counter medicines. Hydroquinone is a white granular solid at room temperature and pressure. The hydroxyl groups of hydroquinone are quite weakly acidic. Hydroquinone can lose an H+ from one of the hydroxyls to form a monophenolate ion or lose an H+ from both to form a diphenolate ion. Hydroquinone has a variety of uses principally associated with its action as a reducing agent which is soluble in water. It is a major component in most photographic developers where, with the compound Metol, it reduces silver halides to elemental silver. [HMDB]. Hydroquinone is found in many foods, some of which are kai-lan, agar, red bell pepper, and jostaberry. |
|---|
| CAS Number | 123-31-9 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 1,4-Benzenediol | ChEBI | | 1,4-Dihydroxybenzene | ChEBI | | 4-Hydroxyphenol | ChEBI | | Benzene-1,4-diol | ChEBI | | Eldoquin | ChEBI | | p-Benzenediol | ChEBI | | p-Hydroquinone | ChEBI | | p-Hydroxyphenol | ChEBI | | Quinol | ChEBI | | Artra | MeSH | | Eldopaque | MeSH | | Esoterica | MeSH | | Hidroquilaude | MeSH | | Hidroquin | MeSH | | Hidroquinona isdin | MeSH | | Licostrata | MeSH | | Lustra | MeSH | | Melanasa | MeSH | | Melanex | MeSH | | Melpaque | MeSH | | Melquin | MeSH | | Neostrata HQ | MeSH | | Phiaquin | MeSH | | Solaquin | MeSH | | Ultraquin | MeSH | | beta-Quinol | MeSH | | Hydroquinone, copper (1+) salt | MeSH | | Hydroquinone, lead (2+) salt (2:1) | MeSH | | Hydroquinone, monocopper (2+) salt | MeSH | | 1,4-Dihydroxy-benzeen | HMDB | | 1,4-Dihydroxy-benzol | HMDB | | 1,4-Dihydroxybenzen | HMDB | | 1,4-Diidrobenzene | HMDB | | a-Hydroquinone | HMDB | | alpha-Hydroquinone | HMDB | | b-Quinol | HMDB | | Benzohydroquinone | HMDB | | Benzoquinol | HMDB | | Dihydroquinone | HMDB | | Dihydroxybenzene | HMDB | | Hydrochinon | HMDB | | Hydrochinone | HMDB | | Hydroquinol | HMDB | | Hydroquinole | HMDB | | Hydroquinone for synthesis | HMDB | | Hydroquinone GR | HMDB | | Hydroquinoue | HMDB | | Idrochinone | HMDB | | p-Dihydroxybenzene | HMDB | | P-Dioxobenzene | HMDB | | p-Dioxybenzene | HMDB | | P-Hydroxybenzene | HMDB | | Solaquin forte | HMDB | | Eldoquin forte | MeSH, HMDB | | Stratus brand 1 OF hydroquinone | MeSH, HMDB | | ICN brand 1 OF hydroquinone | MeSH, HMDB | | Plough brand 2 OF hydroquinone | MeSH, HMDB | | Eldopaque forte | MeSH, HMDB | | ICN brand 4 OF hydroquinone | MeSH, HMDB | | Black and white | MeSH, HMDB | | ICN brand 2 OF hydroquinone | MeSH, HMDB | | ICN brand 3 OF hydroquinone | MeSH, HMDB | | Plough brand 1 OF hydroquinone | MeSH, HMDB | | Stratus brand 2 OF hydroquinone | MeSH, HMDB | | 1,4-Benzoquinol | PhytoBank | | 1,4-Phenylenediol | PhytoBank | | 1,4-p-Benzenediol | PhytoBank | | p-Dihydroquinone | PhytoBank | | p-Phenylenediol | PhytoBank | | p-Quinol | PhytoBank | | Arctuvin | db_source | | Hydroquinone gr | HMDB | | Hydroquinone, 8CI, USAN | db_source | | P-Benzenediol | ChEBI | | P-Dihydroxybenzene | HMDB | | P-Dioxybenzene | HMDB | | P-Hydroquinone | ChEBI | | P-Hydroxyphenol | ChEBI | | Pyrogentisic acid | db_source | | Pyrogentisinic acid | db_source |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C6H6O2 |
|---|
| IUPAC name | benzene-1,4-diol |
|---|
| InChI Identifier | InChI=1S/C6H6O2/c7-5-1-2-6(8)4-3-5/h1-4,7-8H |
|---|
| InChI Key | QIGBRXMKCJKVMJ-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | OC1=CC=C(O)C=C1 |
|---|
| Average Molecular Weight | 110.1106 |
|---|
| Monoisotopic Molecular Weight | 110.036779436 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as hydroquinones. Hydroquinones are compounds containing a hydroquinone moiety, which consists of a benzene ring with a hydroxyl groups at positions 1 and 4. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Phenols |
|---|
| Sub Class | Benzenediols |
|---|
| Direct Parent | Hydroquinones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Hydroquinone
- 1-hydroxy-2-unsubstituted benzenoid
- Monocyclic benzene moiety
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Physiological effect | Health effect: |
|---|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Indirect biological role: Environmental role: Industrial application: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 65.45%; H 5.49%; O 29.06% | DFC |
|---|
| Melting Point | Not Available | |
|---|
| Boiling Point | Bp730 285° | DFC |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | Not Available | |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | [neutral] lmax 250 (e 204) (CHCl3) (Berdy) | DFC |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| EI-MS | Mass Spectrum (Electron Ionization) | splash10-03di-9500000000-1fa8477944a662535e76 | 2014-09-20 | View Spectrum | | GC-MS | Hydroquinone, 2 TMS, GC-MS Spectrum | splash10-0f79-2490000000-6b4fec222a3499d93790 | Spectrum | | GC-MS | Hydroquinone, non-derivatized, GC-MS Spectrum | splash10-03di-9800000000-c90fd4986fea9691ecbf | Spectrum | | GC-MS | Hydroquinone, non-derivatized, GC-MS Spectrum | splash10-03e9-9300000000-f8b11742557329691e8a | Spectrum | | GC-MS | Hydroquinone, non-derivatized, GC-MS Spectrum | splash10-0f79-2490000000-6b4fec222a3499d93790 | Spectrum | | GC-MS | Hydroquinone, non-derivatized, GC-MS Spectrum | splash10-0f79-2690000000-7306adcc7121a11d67cc | Spectrum | | Predicted GC-MS | Hydroquinone, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-03di-5900000000-954dc96d8e3eb85b8324 | Spectrum | | Predicted GC-MS | Hydroquinone, 2 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-00e9-8950000000-512c0cf5ddc0b120ec8e | Spectrum | | Predicted GC-MS | Hydroquinone, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Hydroquinone, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated) | splash10-03di-9600000000-e670ba090cb27367db12 | 2012-07-25 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated) | splash10-01p6-9000000000-5fc32c7688c1612df1e7 | 2012-07-25 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated) | splash10-000i-9000000000-c5853ce8ef225ea5c353 | 2012-07-25 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - EI-B (Unknown) , Positive | splash10-03di-9800000000-c90fd4986fea9691ecbf | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - , negative | splash10-0a4i-0900000000-5635f0157cd37deb1121 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - , positive | splash10-03di-2900000000-05be113033a709130eed | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 20V, Negative | splash10-0a4i-9600000000-e0d15b2e4ea35a7a76be | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 20V, Positive | splash10-01r6-9000000000-946504408977df40269a | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Negative | splash10-0a4i-0900000000-c16180dd26c127563155 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 40V, Positive | splash10-03dl-9000000000-cea1cb486f12ea31e3a1 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Positive | splash10-01ox-9000000000-3a9d5710c88793e698f1 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 40V, Negative | splash10-0006-9000000000-60eeaa79bff371773b2e | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 20V, Negative | splash10-0a4i-0900000000-3a9e293da186985db7fa | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 40V, Negative | splash10-0pb9-9000000000-84bb0a9b4c3cd16da2a7 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Negative | splash10-0a4i-7900000000-2256214c81a3e04e01b7 | 2021-09-20 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03di-0900000000-8d8328e4f7cd2ebaa27d | 2015-05-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-1900000000-9290fcb93f170fc3143f | 2015-05-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-01si-9200000000-9f707b9d0c4ad0b73b30 | 2015-05-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0a4i-0900000000-d3aae38632ac4c40fd4f | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0a4i-0900000000-74f15490ba4f49cf8c18 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0a4i-9800000000-1cb01248e88fce387578 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0a4i-0900000000-9f2c82efe2cba7470e17 | 2021-09-22 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0a4i-0900000000-9f2c82efe2cba7470e17 | 2021-09-22 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0f6x-9000000000-8213c13cc381b346f976 | 2021-09-22 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03di-0900000000-fd10fd64675560620b8d | 2021-09-22 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, DMSO-d6, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 15.08 MHz, DMSO-d6, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 764 |
|---|
| ChEMBL ID | CHEMBL537 |
|---|
| KEGG Compound ID | C00530 |
|---|
| Pubchem Compound ID | 785 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | Not Available |
|---|
| Phenol-Explorer ID | 660 |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB02434 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | BLQ78-M:BLQ78-M |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | HYDROQUINONE|P-HYDROQUINONE |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | C00002656 |
|---|
| HET ID | HQE |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Not Available |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Allelochemic | | A chemical released by plants that interacts with other organisms, influencing their behavior or growth. Its biological role involves plant defense and communication. Therapeutically, allelochemics have anti-inflammatory, antimicrobial, and antioxidant properties, with applications in managing anxiety, pain, and infections, as well as potential anticancer uses. | DUKE | | Allergenic | 50904 | A substance that triggers an immune response, causing allergic reactions. Its biological role is to stimulate the immune system, but it has no therapeutic applications. Key medical uses include diagnosing allergies and developing immunotherapies to desensitize patients to specific allergens, reducing the risk of severe reactions. | DUKE | | Anti bacterial | 33282 | An agent that inhibits the growth of or destroys bacteria, playing a crucial role in preventing and treating infections. Therapeutically, it is used to combat bacterial infections, with key medical applications including treating pneumonia, tuberculosis, and skin infections, as well as preventing surgical site infections and sepsis. | DUKE | | Anti hepatomic | 35610 | An agent that inhibits the growth of liver cancer cells, playing a role in cancer treatment. Therapeutically, it is used to manage liver cancer, reducing tumor size and slowing disease progression. Key medical uses include treating hepatocellular carcinoma and other liver malignancies, improving patient outcomes and quality of life. | DUKE | | Anti-lithic | | An agent that prevents the formation of calculi (kidney stones) or promotes their dissolution, playing a key role in urology. Its therapeutic applications include managing kidney stone disease, nephrolithiasis, and urinary tract disorders, helping to alleviate pain and prevent complications. | DUKE | | Anti-malarial | 33281 | An agent that prevents or treats malaria, a disease caused by Plasmodium parasites. It works by targeting the parasite's life cycle, reducing symptoms and preventing transmission. Therapeutically, anti-malarials are used to treat and prevent malaria, as well as to manage related conditions such as babesiosis and toxoplasmosis. | DUKE | | Anti-melanomic | 35610 | An agent that inhibits melanin production, reducing melanoma cell growth. It has therapeutic applications in treating skin cancers, particularly melanoma, and key medical uses include preventing tumor progression and metastasis, as well as managing pigmentation disorders. | DUKE | | Anti-melasmic | | An agent that reduces melasma, a skin discoloration condition, by inhibiting melanin production. It is therapeutically used to treat hyperpigmentation, commonly occurring during pregnancy or hormonal changes, and has key medical applications in dermatology for skin whitening and brightening treatments. | DUKE | | Anti-menorrhagic | 52217 | An agent that reduces heavy menstrual bleeding, playing a biological role in regulating menstrual flow. Therapeutically, it is used to treat menorrhagia, with key medical applications including managing excessive uterine bleeding, dysmenorrhea, and menstrual disorders. | DUKE | | Anti mitotic | | An agent that inhibits mitosis, or cell division, playing a crucial role in regulating cell growth. Therapeutically, it is used to treat cancer by blocking tumor cell proliferation. Key medical uses include chemotherapy for various cancers, such as breast, lung, and colon cancer, to prevent cancer cell division and growth. | DUKE | | Anti nephritic | 52217 | An agent that reduces kidney inflammation, commonly used to manage nephritis and other kidney disorders, helping to prevent kidney damage and promote renal health. | DUKE | | Anti-oxidant | 22586 | An agent that neutralizes free radicals, reducing oxidative stress and cell damage. Its biological role involves protecting cells from harm, and it has therapeutic applications in managing chronic diseases, such as cancer, diabetes, and neurodegenerative disorders, with key medical uses including anti-aging, anti-inflammatory, and cardio protective effects. | DUKE | | Anti-pertussive | 33282 | An agent that reduces the severity of pertussis (whooping cough) symptoms, commonly used to manage coughing fits and respiratory distress associated with the disease, often prescribed in combination with antibiotics to alleviate symptoms and prevent complications. | DUKE | | Anti septic | 33281 | An agent that prevents or reduces the growth of microorganisms, such as bacteria, fungi, or viruses, to promote wound healing and prevent infection. Therapeutically, anti septics are used to treat minor cuts, scrapes, and burns, and are commonly applied topically to reduce the risk of infection and promote tissue repair. Key medical uses include wound care, surgical site preparation, and skin infection management. | DUKE | | Anti-thyreotropic | | An antibody that inhibits thyrotropin, regulating thyroid hormone production. It has therapeutic applications in managing thyroid disorders, such as hyperthyroidism, and key medical uses include treating conditions like Graves' disease. | DUKE | | Anti trypanosomic | 33281 | An agent that targets and eliminates trypanosomes, parasites causing diseases like sleeping sickness and Chagas disease. It plays a crucial role in treating and preventing these diseases, with therapeutic applications in tropical medicine and key medical uses in treating parasitic infections. | DUKE | | Antitumor | 35610 | An agent that inhibits tumor growth and proliferation, playing a crucial role in cancer treatment. Therapeutically, antitumors are used to manage various types of cancer, including chemotherapy, targeted therapy, and immunotherapy, helping to reduce tumor size, prevent metastasis, and improve patient outcomes. | DUKE | | Astringent | 74783 | An agent that constricts or shrinks tissues, reducing bleeding and inflammation. It plays a biological role in wound healing and has therapeutic applications in treating hemorrhoids, diarrhea, and skin irritations. Key medical uses include reducing swelling, stopping bleeding, and protecting mucous membranes, making it useful in various topical and oral preparations. | DUKE | | Carcinogenic | 50903 | An agent that causes cancer, damaging cellular DNA and disrupting normal cell growth. It has no therapeutic applications, but understanding its biological role informs cancer prevention and treatment strategies, with key medical uses in oncology research and risk assessment. | DUKE | | Convulsant | | An agent that induces convulsions and/or epileptic seizures, acting as a stimulant at low doses. It has no therapeutic applications due to its high risk of causing seizures and excitotoxicity, and is the opposite of an anticonvulsant. | DUKE | | Cytotoxic | 52209 | An agent that kills or damages cells, playing a biological role in immune responses and therapeutic applications in cancer treatment. Key medical uses include chemotherapy, targeting and destroying cancer cells, and treating certain autoimmune diseases by eliminating harmful cells. | DUKE | | Deliriant | | A class of hallucinogen that induces solid hallucinations, seamlessly integrating into waking consciousness. It has no established therapeutic applications, but is sometimes used in research to study psychosis and altered states of consciousness. Medical uses are limited due to its potent hallucinogenic effects. | DUKE | | Depigmentor | | A pigment-suppressing agent that lightens skin, used to treat hyperpigmentation disorders, such as melasma and vitiligo, and has therapeutic applications in dermatology for skin tone evening and brightening. | DUKE | | Emetic | | An agent that induces vomiting, playing a biological role in expelling toxins from the body. Therapeutically, it is used to treat poisoning, overdose, or gastrointestinal obstruction. Key medical uses include managing drug toxicity and aiding in stomach pumping procedures. | DUKE | | Name | 48318 | flavor | DUKE | | Herbicide | 24527 | A chemical agent that kills or inhibits plant growth, used in agriculture to control weeds and pests. It has no direct biological role or therapeutic applications in human medicine, but its development has led to the creation of related compounds with potential medical uses, such as anticancer agents. | DUKE | | Hypertensive | | An agent that increases blood pressure, used therapeutically to treat hypotension (low blood pressure) and shock, and medically to manage conditions such as orthostatic hypotension and postural hypotension. | DUKE | | Irritant | | An agent that causes slight inflammation or discomfort, stimulating a biological response. Therapeutically, it can be used to increase blood flow or stimulate healing. Key medical uses include treating wounds, skin conditions, and respiratory issues, such as congestion, by inducing a mild inflammatory response to promote recovery. | DUKE | | Mycoplasma inhibitor | | An agent that inhibits growth of Mycoplasma bacteria, used therapeutically to treat Mycoplasma infections, with applications in managing respiratory and urogenital diseases. | DUKE | | Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE | | Tinnitigenic | 52217 | An agent that induces or exacerbates tinnitus, often used in research to study the condition. Its biological role involves stimulating auditory pathways, and it has therapeutic applications in understanding and developing treatments for tinnitus and hearing disorders. Key medical uses include researching tinnitus mechanisms and testing potential treatments. | DUKE |
|
|---|
| Enzymes | | Name | Gene Name | UniProt ID |
|---|
| Serum paraoxonase/lactonase 3 | PON3 | Q15166 | | Serum paraoxonase/arylesterase 1 | PON1 | P27169 | | Serum paraoxonase/arylesterase 2 | PON2 | Q15165 |
|
|---|
| Pathways | | Name | SMPDB Link | KEGG Link |
|---|
| Metabolism and Physiological Effects of Orotic acid | SMP0124870 | Not Available | | Metabolism and Physiological Effects of Uridine | SMP0124871 | Not Available | | Metabolism and Physiological Effects of Oxalic acid | SMP0124875 | Not Available |
|
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181.
|
|---|